NeuroSense Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.

About NRSN

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS).

CEO

Alon Ben-Noon

CEOAlon Ben-Noon

Employees

Employees15

Headquarters

Herzliya, Tel Aviv

HeadquartersHerzliya, Tel Aviv

Founded

2017

Founded2017

Employees

Employees15

NRSN Key Statistics

Market cap

28.19M

Market cap28.19M

Price-Earnings ratio

-2.01

Price-Earnings ratio-2.01

Dividend yield

—

Dividend yield—

Average volume

360.68K

Average volume360.68K

High today

$1.19

High today$1.19

Low today

$1.11

Low today$1.11

Open price

$1.15

Open price$1.15

Volume

216.79K

Volume216.79K

52 Week high

$2.60

52 Week high$2.60

52 Week low

$0.6729

52 Week low$0.6729

People also own

Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.